The medical diagnostics company has secured a second round of funding, totalling $13m, and Dow Chemical is among the backers.
US-based chemical multinational Dow Chemical Company is among the investors which have contributed to a $13m round of series B funding for local medical diagnostics company NanoMR.
The round was led by US-based venture capital (VC) firm Excel Venture Management, and also participated in by peers Healthcare Ventures, VSpring Capital and Sun Mountain Capital.
VSpring and Sun Mountain had previously joined Dow in investing in NanoMR’s A round in June 2008, which raised $5.5m. The company has raised at least…
